Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction
出版年份 2020 全文链接
标题
Changes in Cardiovascular Biomarkers With Breast Cancer Therapy and Associations With Cardiac Dysfunction
作者
关键词
-
出版物
Journal of the American Heart Association
Volume 9, Issue 2, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2020-01-21
DOI
10.1161/jaha.119.014708
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Anthracycline-induced cardiotoxicity: A multicenter randomised trial comparing two strategies for guiding prevention with enalapril: The International CardioOncology Society-one trial
- (2018) Daniela Cardinale et al. EUROPEAN JOURNAL OF CANCER
- Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens
- (2018) Aurelia H. M. de Vries Schultink et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Carvedilol for Prevention of Chemotherapy-Related Cardiotoxicity
- (2018) Mônica Samuel Avila et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- N-Terminal Pro–B-Type Natriuretic Peptide in the Emergency Department
- (2018) James L. Januzzi et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Role of Troponins I and T and N-Terminal Prohormone of Brain Natriuretic Peptide in Monitoring Cardiac Safety of Patients With Early-Stage Human Epidermal Growth Factor Receptor 2–Positive Breast Cancer Receiving Trastuzumab: A Herceptin Adjuvant Study Cardiac Marker Substudy
- (2017) Dimitrios Zardavas et al. JOURNAL OF CLINICAL ONCOLOGY
- Multidisciplinary Approach to Novel Therapies in Cardio-Oncology Research (MANTICORE 101–Breast): A Randomized Trial for the Prevention of Trastuzumab-Associated Cardiotoxicity
- (2017) Edith Pituskin et al. JOURNAL OF CLINICAL ONCOLOGY
- Prevention and Monitoring of Cardiac Dysfunction in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
- (2017) Saro H. Armenian et al. JOURNAL OF CLINICAL ONCOLOGY
- Arginine-Nitric Oxide Metabolites and Cardiac Dysfunction in Patients With Breast Cancer
- (2017) Brian S. Finkelman et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- The Role of Biomarkers in Detection of Cardio-toxicity
- (2017) Kevin S. Shah et al. Current Oncology Reports
- Neurohormonal Blockade and Circulating Cardiovascular Biomarkers During Anthracycline Therapy in Breast Cancer Patients: Results From the PRADA (Prevention of Cardiac Dysfunction During Adjuvant Breast Cancer Therapy) Study
- (2017) Geeta Gulati et al. Journal of the American Heart Association
- A Population-Based Study of Cardiovascular Mortality Following Early-Stage Breast Cancer
- (2017) Husam Abdel-Qadir et al. JAMA Cardiology
- On longitudinal prediction with time-to-event outcome: Comparison of modeling options
- (2016) Marlena Maziarz et al. BIOMETRICS
- Cancer Therapy–Related Cardiac Dysfunction and Heart Failure
- (2016) Carine E. Hamo et al. Circulation-Heart Failure
- Prevention of cardiac dysfunction during adjuvant breast cancer therapy (PRADA): a 2 × 2 factorial, randomized, placebo-controlled, double-blind clinical trial of candesartan and metoprolol
- (2016) Geeta Gulati et al. EUROPEAN HEART JOURNAL
- 2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines
- (2016) Jose Luis Zamorano et al. EUROPEAN HEART JOURNAL
- High-Sensitivity Cardiac Troponin, Statin Therapy, and Risk of Coronary Heart Disease
- (2016) Ian Ford et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Noninvasive Measures of Ventricular-Arterial Coupling and Circumferential Strain Predict Cancer Therapeutics–Related Cardiac Dysfunction
- (2016) Hari K. Narayan et al. JACC-Cardiovascular Imaging
- Longitudinal Changes in Multiple Biomarkers Are Associated with Cardiotoxicity in Breast Cancer Patients Treated with Doxorubicin, Taxanes, and Trastuzumab
- (2015) M. Putt et al. CLINICAL CHEMISTRY
- Roadmap for biomarkers of cancer therapy cardiotoxicity
- (2015) Anthony F Yu et al. HEART
- Longitudinal Assessment of Concurrent Changes in Left Ventricular Ejection Fraction and Left Ventricular Myocardial Tissue Characteristics After Administration of Cardiotoxic Chemotherapies Using T1-Weighted and T2-Weighted Cardiovascular Magnetic Resonance
- (2014) Jennifer H. Jordan et al. Circulation-Cardiovascular Imaging
- Elevation in High-Sensitivity Troponin T in Heart Failure and Preserved Ejection Fraction and Influence of Treatment With the Angiotensin Receptor Neprilysin Inhibitor LCZ696
- (2014) Pardeep S. Jhund et al. Circulation-Heart Failure
- BNP Predicts Chemotherapy-Related Cardiotoxicity and Death: Comparison with Gated Equilibrium Radionuclide Ventriculography
- (2014) Dorthe Skovgaard et al. PLoS One
- The potential role of NT-proBNP in screening for and predicting prognosis in heart failure: a survival analysis
- (2014) C J Taylor et al. BMJ Open
- Natriuretic Peptide–Based Screening and Collaborative Care for Heart Failure
- (2013) Mark Ledwidge et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Early Increases in Multiple Biomarkers Predict Subsequent Cardiotoxicity in Patients With Breast Cancer Treated With Doxorubicin, Taxanes, and Trastuzumab
- (2013) Bonnie Ky et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Assessment of Echocardiography and Biomarkers for the Extended Prediction of Cardiotoxicity in Patients Treated With Anthracyclines, Taxanes, and Trastuzumab
- (2012) Heloisa Sawaya et al. Circulation-Cardiovascular Imaging
- Effect of Serelaxin on Cardiac, Renal, and Hepatic Biomarkers in the Relaxin in Acute Heart Failure (RELAX-AHF) Development Program
- (2012) Marco Metra et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Early Detection and Prediction of Cardiotoxicity in Chemotherapy-Treated Patients
- (2011) Heloisa Sawaya et al. AMERICAN JOURNAL OF CARDIOLOGY
- Serial measurements of NT-proBNP are predictive of not-high-dose anthracycline cardiotoxicity in breast cancer patients
- (2011) S Romano et al. BRITISH JOURNAL OF CANCER
- Troponin I and C-Reactive Protein Are Commonly Detected in Patients with Breast Cancer Treated with Dose-Dense Chemotherapy Incorporating Trastuzumab and Lapatinib
- (2011) P. G. Morris et al. CLINICAL CANCER RESEARCH
- Biomarker Approach to the Detection and Cardioprotective Strategies During Anthracycline Chemotherapy
- (2011) Bonnie Ky et al. Heart Failure Clinics
- Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation
- (2010) Daniela Cardinale et al. JOURNAL OF CLINICAL ONCOLOGY
- Myeloperoxidase: A Useful Biomarker for Cardiovascular Disease Risk Stratification?
- (2009) R. K. Schindhelm et al. CLINICAL CHEMISTRY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started